Illumina (ILMN) Stock Overview
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
ILMN Community Fair Values
Create NarrativeSee what 70 others think this stock is worth. Follow their fair value or set your own to get alerts.
Illumina, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$95.12 |
| 52 Week High | US$156.66 |
| 52 Week Low | US$68.70 |
| Beta | 1.43 |
| 1 Month Change | -4.98% |
| 3 Month Change | 5.40% |
| 1 Year Change | -26.37% |
| 3 Year Change | -52.41% |
| 5 Year Change | -67.81% |
| Change since IPO | 385.65% |
Recent News & Updates
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Aug 31
Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues
Aug 08Illumina, Inc. Just Recorded A 76% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 05Illumina: The Stock Is Still Undervalued
Aug 04Recent updates
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Aug 31Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues
Aug 08Illumina, Inc. Just Recorded A 76% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 05Illumina: The Stock Is Still Undervalued
Aug 04Illumina, Inc.'s (NASDAQ:ILMN) Shareholders Might Be Looking For Exit
Jul 09These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well
Jun 13Illumina, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 13Is Illumina Undervalued After An 83% Drop In Its Stock Price?
Mar 27Risks Still Elevated At These Prices As Illumina, Inc. (NASDAQ:ILMN) Shares Dive 35%
Mar 06Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Mar 05Illumina (NASDAQ:ILMN) Seems To Use Debt Quite Sensibly
Feb 07Illumina, Inc.'s (NASDAQ:ILMN) Price Is Out Of Tune With Revenues
Jan 20Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated
Dec 19What Does Illumina, Inc.'s (NASDAQ:ILMN) Share Price Indicate?
Dec 12Calculating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Nov 24Illumina: Q3 Confirms Improving Fundamentals
Nov 05We Think Illumina (NASDAQ:ILMN) Can Stay On Top Of Its Debt
Oct 21Illumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)
Aug 21Illumina: Strengthening Competitive Position, Relevance And A Very Compelling Valuation
Jul 23Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out
Jun 28Illumina: Expect A Slow Rebound
May 07Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition
Feb 23Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024
Jan 19Shareholder Returns
| ILMN | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -3.9% | -2.9% | 1.7% |
| 1Y | -26.4% | -22.5% | 18.7% |
Return vs Industry: ILMN underperformed the US Life Sciences industry which returned -22.5% over the past year.
Return vs Market: ILMN underperformed the US Market which returned 18.7% over the past year.
Price Volatility
| ILMN volatility | |
|---|---|
| ILMN Average Weekly Movement | 5.4% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ILMN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ILMN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 9,000 | Jacob Thaysen | www.illumina.com |
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.
Illumina, Inc. Fundamentals Summary
| ILMN fundamental statistics | |
|---|---|
| Market cap | US$14.63b |
| Earnings (TTM) | US$1.26b |
| Revenue (TTM) | US$4.28b |
Is ILMN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ILMN income statement (TTM) | |
|---|---|
| Revenue | US$4.28b |
| Cost of Revenue | US$1.36b |
| Gross Profit | US$2.92b |
| Other Expenses | US$1.66b |
| Earnings | US$1.26b |
Last Reported Earnings
Jun 29, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.17 |
| Gross Margin | 68.16% |
| Net Profit Margin | 29.34% |
| Debt/Equity Ratio | 88.2% |
How did ILMN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/14 13:53 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/06/29 |
| Annual Earnings | 2024/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Illumina, Inc. is covered by 57 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| James Francis Mainwaring | Atlantic Equities LLP |
| Catherine Ramsey Schulte | Baird |